Meal consumption in the evening is greater in obese adolescents compared with overweight or normal weight subjects, with later circadian phase of peak intake and lower amplitude.
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Treatment for adolescent obesity should be guided by patient age, pubertal status, severity of obesity, psychosocial factors, and comorbidities.
A class of diabetes drugs, called sodium-glucose co-transporter-2 inhibitors, protect against kidney disease in patients with type 2 diabetes.
The diagnosis of osteoporosis was overrepresented in patients receiving high-dose and underrepresented in patients receiving low-dose statin treatment.
In a study, elevated FGF23 was associated with increased risks of major adverse cardiovascular events and mortality in type 2 diabetes patients with normal or mildly impaired kidney function.
Investigators analyzed the potential metabolic effects of lurasidone in a sample of patients with bipolar I depression.
There is a substantial burden, unawareness, and undertreatment of several systemic comorbidities—particularly cardiovascular and psychiatric—in patients with HS.
Visual symptoms are a vital component of the morbidity encountered in patients with pituitary adenoma, can present at all stages of the disease, and may negatively affect daily activities and overall quality of life, a new review claims.
In a multicenter Italian study, researchers aimed to assess the results of somatostatin analogue treatment at non-conventional doses in patients with radiologic progression of neuroendocrine tumors.
Please login or register first to view this content.
